[1]孙 杰,李 洋.系统性硬化症纤维化治疗新靶点研究[J].医学信息,2018,31(09):56-58.[doi:10.3969/j.issn.1006-1959.2018.09.018]
 SUN Jie,LI Yang.A New Target for the Treatment of Systemic Sclerosis with Fibrosis[J].Journal of Medical Information,2018,31(09):56-58.[doi:10.3969/j.issn.1006-1959.2018.09.018]
点击复制

系统性硬化症纤维化治疗新靶点研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年09期
页码:
56-58
栏目:
综述
出版日期:
2018-05-01

文章信息/Info

Title:
A New Target for the Treatment of Systemic Sclerosis with Fibrosis
文章编号:
1006-1959(2018)09-0056-03
作者:
孙 杰李 洋
哈尔滨医科大学附属第二医院风湿免疫科,黑龙江 哈尔滨 150086
Author(s):
SUN JieLI Yang
Department of Rheumatological Immunology,Second Affiliated Hospital of Harbin Medical University, Harbin 150086,Heilongjiang,China
关键词:
系统性硬化症纤维化靶点
Keywords:
Key words:Systemic sclerosisFibrosisTarget
分类号:
R593.2
DOI:
10.3969/j.issn.1006-1959.2018.09.018
文献标志码:
A
摘要:
系统性硬化症是一种以局限性或弥漫性皮肤增厚和纤维化为主要特征,可引起多系统损害的结缔组织病。纤维化作为系统性硬化症患者主要的死亡原因,每年可造成巨大的社会经济影响。近年来对系统性硬化症纤维化治疗新靶点的研究已成为一个新热点,本文主要围绕系统性硬化症纤维化发生的病理生理学基础和治疗新靶点这两方面加以阐述。
Abstract:
Abstract:Systemic sclerosis is a connective tissue disease that is characterized by localized or diffuse skin thickening and fibrosis that can cause multiple systemic damage.Fibrosis,the leading cause of death in patients with systemic sclerosis,can cause significant socio-economic impact each year.In recent years,the study of new targets for the treatment of systemic sclerosis fibrosis has become a new hot spot.This article focuses on the pathophysiology of systemic sclerosis fibrosis and the treatment of new targets in two aspects.

参考文献/References:

[1]Rubio-Rivas M,Royo C,Simeón CP,et al.Mortality and survival in systemic sclerosis:systematic review and meta-analysis[J].Semin Arthritis Rheum,2014,44(2):208-219.
[2]Nadia D,Morgan,MBBS,et al.Clinical and serological features of systemicsclerosis in a multicenter African American cohort[J].Medicine,2017(96):51.
[3]Bagalad BS,Mohan Kumar KP,Puneeth HK,et al.Myofibroblasts:Master of disguise[J].J Oral Maxillofac Pathol,2017,21(3):462-463.
[4]Pakshir P,Hinz B.The big five in fibrosis:Macrophages,myofibroblasts,matrix,mechanics,and miscommunication[J].Matrix Biol,2018.
[5]Marangoni RG,Korman BD,Wei J,et al.Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors[J].Arthritis Rheumatol,2015,(67):1062-1073.
[6]PardaliE,Sanchez-Duffhues G,Gomez-Puerto MC,et al. TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases[J].Int J Mol Sci,2017,18(10):2157.
[7]Cho N,Razipour S E,Mccain M L.TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts[J].Experimental Biology& Medicine,2018:1535370218761628.
[8]Manetti M,Romano E,Rosa I,et al.Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis[J].Ann Rheum Dis,2017(76):924-934.
[9]Gwilym JW,Gideon MH,PeterJL,et al.OX40,OX40Land Autoimmunity:a Comprehensive Review[J].Clinical Reviews in Allergy&Immunology,2016,50(3):312-332.
[10]Elhai M,Avouac J,Hoffmannvold A M,et al.OX40L blockade protects against inflammation-driven fibrosis[J].Proc Natl Acad Sci U S A,2016,113(27):E3901.
[11]姜雨,丁怡,李文卿,等.STAT3对EMT的调节和对循环肿瘤细胞与肿瘤侵袭及转移的影响[J].生物化学与生物物理进展,2016,43(7):644-651.
[12]Hua Y,Heehyoung L,Andreas H,et al.Revisiting STAT3 signalling in cancer:new and unexpected biological functions[J].Nature Reviews Cancer,2014,14:736-746.
[13]Hillmer E J,Zhang H,Li H S,et al.STAT3 signaling in immunity[J].Cytokine&Growth Factor Reviews,2016(31):1-15.
[14]Chakraborty D,umová B,Mallano T,et al.Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis[J].Nature Communications,2017,8(1):1130.
[15]周立军,刘文娟,祁永浩,等.SOCS3通过JNK和STAT3信号通路调控AKT[J].中国生物工程杂,2015,35(9):50-56.
[16]Yin Y,Liu W,Dai Y.SOCS3 and its role in associated diseases[J].Human Immunology,2015,76(10):775-780.
[17]Clara Dees,Yun Z,Sebastian P,et al.TGF-β-Induced Epigenetic Silencing of SOCS3 Facilitates STAT3 Signaling to Promote Fibroblast Activation and Tissue Fibrosis in Systemic Sclerosis[A].2017 ACR ARHP Annual Meeting,2017(9):18.
[18]Jia Y,Li P,Fang L,et al.Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer[J].Cell Discov,2016(2):16007.
[19]Koh HB,Scruggs AM,Huang SK,et al.Transforming Growth Factor-β1 Increases DNA Methyltransferase 1 and 3a Expression through Distinct Post-transcriptional Mechanisms in Lung Fibroblasts[J].J Biol Chem,2016,291(37):19287-19298.
[20]Hinz B,Phan SH,Thannickal VJ,et al.Recent developments in myofibroblast biology:paradigms for connective tissue remodeling[J].Am J Pathol,2012,180(4):1340-1355.
[21]Mann J,Mann DA.Epigenetic regulation of wound healing and fibrosis[J].Curr Opin Rheumatol,2013,25(1):101-107.
[22]Takahashi T,Asano Y,Sugawara K,et al.Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis:Possible roles in scleroderma[J].Journal of Experimental Medicine,2017,214(4):20160247.

相似文献/References:

[1]程丽丽,黄传兵,汤忠富,等.从肺论治系统性硬化症合并间质性肺病的经验举隅[J].医学信息,2022,35(10):155.[doi:10.3969/j.issn.1006-1959.2022.10.039]
[2]王海燕,唐小葵.系统性硬化症相关间质性肺病的治疗[J].医学信息,2018,31(19):60.[doi:10.3969/j.issn.1006-1959.2018.19.020]
 WANG Hai-yan,TANG Xiao-kui.Treatment of Systemic Sclerosis-related Interstitial Lung Disease[J].Journal of Medical Information,2018,31(09):60.[doi:10.3969/j.issn.1006-1959.2018.19.020]
[3]李志俊,王 利,王 浩.姜黄素改善糖尿病肾病的作用机制研究[J].医学信息,2018,31(24):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
 LI Zhi-jun,WANG Li,WANG Hao.Study on the Mechanism of Curcumin in Improving Diabetic Nephropathy[J].Journal of Medical Information,2018,31(09):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
[4]翟 薇,刘 蓓.脂联素与肝纤维化的研究进展[J].医学信息,2020,33(08):22.[doi:10.3969/j.issn.1006-1959.2020.08.009]
 ZHAI Wei,LIU Bei.The Relationship Between Adiponectin and Liver Fibrosis of Nonalcoholic Fatty Liver and Liver Fibrosis[J].Journal of Medical Information,2020,33(09):22.[doi:10.3969/j.issn.1006-1959.2020.08.009]
[5]阿丽米热·阿不都热依木,宋 涛.实时剪切波弹性成像在肾小球肾炎早期诊断中的应用价值[J].医学信息,2020,33(09):90.[doi:10.3969/j.issn.1006-1959.2020.09.026]
 Alimire Abdul Yimu,SONG Tao.Application Value of Real-time Shear Wave Elastography Elasticity in Early Diagnosis of Glomerulonephritis[J].Journal of Medical Information,2020,33(09):90.[doi:10.3969/j.issn.1006-1959.2020.09.026]
[6]刘孟国,傅雯雯.警报素在系统性硬化症发病机制中的作用[J].医学信息,2021,34(04):40.[doi:10.3969/j.issn.1006-1959.2021.04.011]
 LIU Meng-guo,FU Wen-wen.The Role of Alarmins in the Pathogenesis of Systemic Sclerosis[J].Journal of Medical Information,2021,34(09):40.[doi:10.3969/j.issn.1006-1959.2021.04.011]
[7]陈 英,周淑红,王 妍,等.硬皮病相关间质性肺病与特发性肺纤维化的临床比较[J].医学信息,2023,36(10):53.[doi:10.3969/j.issn.1006-1959.2023.10.013]
 CHEN Ying,ZHOU Shu-hong,WANG Yan,et al.Clinical Comparison Between Scleroderma Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis[J].Journal of Medical Information,2023,36(09):53.[doi:10.3969/j.issn.1006-1959.2023.10.013]
[8]李 颖,张再伟.miRNA在急性心肌梗死早期诊断中的作用及其机制研究[J].医学信息,2022,35(05):40.[doi:10.3969/j.issn.1006-1959.2022.05.010]
 LI Ying,ZHANG Zai-wei.The Role and Mechanism of miRNA in Early Diagnosis of Acute Myocardial Infarction[J].Journal of Medical Information,2022,35(09):40.[doi:10.3969/j.issn.1006-1959.2022.05.010]

更新日期/Last Update: 2018-05-01